Report Description

Cell cultures are essential tools that are used in a wide range of clinical in vitro research studies. 3D cell culture provides an artificial environment which permit biological cells to grow in three dimensions to provide better result than 2D cell culture which is grown in petri dish. Ongoing trend in the development of novel therapies that are more effective, reliable, and safe is prevailing in 3D cell culture market. The global 3D cell culture market is expected to grow with a CAGR of 23.7% during 2016-2023.

The 3D cells cultures are usually grown in a small capsule or bioreactor in which the cell can grow in any shape 3D or spheroid. 3D culture exhibit a higher degree of structural complexity a homeostasis which is analogous to tissues and organs. Advantages of 3D cell culture are proximity of other cells on all side behavior similar to invivo condition and more accurate representation of cyto architecture. These type of culture can also be used as stimulators of tumor characteristic such as hypoxia, anti-apoptotic and dormancy. From past several years tremendous efforts has been put in development of as well as use of 3D cell culture in stem cells study, drug discovery, tissue implantation cancer study etc. 3D cell culture is widely used in research labs, hospitals, and pharmaceutical, biopharmaceutical & biotechnology firm and their use is expected to increase in forecast period. Cell biologics, and increasing incident of various chronic diseases such as hepatitis, HIV, cancer etc. are expected to drive 3D cell culture market. New innovations in tissue engineering and 3D printing technology have increased organ harvesting and transplant. Cell based therapies in hospitals and diagnostic centers for oncology patient are set to propel 3D cell culture market for the forecast period. Increasing cell based research, new innovations in cell culture, technological advancements in cell biology research and rising funding for research related activities are some drivers for the market. High investments for cell biology research and shortage of infrastructure for cell based research in emerging countries are few restraints hindering the market growth while factors such as growing demand for organ transplant and increasing R&D investments providing opportunities in forecast period.

Source: OBRC Analysis

The global 3D cell culture market is segmented into technology, applications and end users. Technology segmented, is further sub segmented into:

With scaffold
Without scaffold

Application segment is sub segmented into:

Tissue engineering
Cell based assay
Oncology

In vivo applications of stem cells:

3D printing
Other applications

End user segment is classified into:

Biotechnology and pharmaceutical industries
Research laboratories
Hospitals and diagnostic centers
Other end users

The revenue for the above application and end-user segment are specific to the 3D cell culture market. However, the total revenue of these application and end-users in general has been excluded from the scope of the report.

Geographically, the global 3D cell culture market has been segmented on the basis of four major region, which include:

North America (U.S. & Canada)
Asia Pacific (China, India, Japan, RoAPAC)
Europe (UK, France, Germany, RoE)
Rest of World

North America is accounted for the largest share of 3D cell culture market and dominating 3d cell culture market. North American markets are driven by demand for organ transplants and increasing demand of research especially in oncology, favorable regulatory environment and increase in expenditure for healthcare sector are also driving North America 3D cell culture market. Europe is the second largest region in 3D cell culture market. Increasing research towards cell biology, biotechnology and oncology both at university and industrial levels are driving the growth of 3D Cell Culture market in Europe, for the forecast period. UK and Germany are the leading market in Europe for 3D cell culture with increasing investments for cancer research.

Asia Pacific is the fastest growing market for 3D cell culture market. Increasing government investment in the area of cell biology and oncology research, growing talent pool towards cell biology research, and new regulatory reforms are the driving force behind 3D Cell culture market in Asia Pacific. China and India are the leading markets in Asia Pacific, with growing awareness of organ transplantation and increasing investment cancer research being the driving factors. Medical tourism is also a factor in growth of 3d cell culture market in APAC.

The research report is segmented in terms of technology, applications, and end users. Technology segmented, is further sub segmented into with scaffold and without scaffold. Without scaffold technology segment is divided further into 3D bioreactors, 3D petri-dishes, 3D bio-printing, microfluidics and hanging drop plates. With scaffold technology segments is classified into solid structure scaffold, hydrogels/ECM and micro-patterned surfaces. Scaffold-based 3D cell culture products is expected to dominate due to its ability to mimic in vivo conditions. Application segment is sub segmented into tissue engineering, cell based assay, oncology, in vivo applications of stem cells, 3D printing, and other applications. Cancer and stem cell research segment is projected to grow with highest CAGR due to increasing incidences of cancer and significant funding initiatives for cancan research. End user segment is classified into biotechnology and pharmaceutical industries, research laboratories, hospitals and diagnostic centers, and other end users. Biotechnology and pharmaceutical industries are the leading end user segment for 3D cell culture market for the forecast period.

The major market players of the global 3D cell culture market are:

3D BIOTEK LLC.
BELL BROOK LABS
CORNING INCOPORATED
GLOBAL CELL SOLUTIONS
HI MEDIA LABORATORIES
KURRAY CO. LTD.
LONZA A. G.
PROMOCELLGMBH.
SIGMA-ALDRICH CO. LLC
THERMO FISHER SCIENTIFIC LTD.
OTHERS

Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching. Example Pluristem Therapeutics on 15th April 2016 was granted patent by Japan Patent Office on 3D cell culture method for cell based therapies from placental cells against hematopoietic diseases caused by chemotherapy or failed transplants. Also, Lonza Group Ltd. signed an agreement with TAP Biosystems on July 2015 to distribute the companies’ 3D cell culture system. Moreover, in 2016, Thermo fisher acquired MTI-Globalstem to bolster its stem cell technology and reagent business.

Why to buy the report:

This report will:

Provide you the business strategies adopted by market player such as Thermo fisher acquired MTI-Globalstem to bolster its stem cell technology and reagent business.
Provide in detail the different segments such as by technology, application and end-users which are affecting the global 3D cell culture market.
Provide you the patent analysis of the 3D cell culture market.
Identify and understand the strength, opportunities, challenges and threat of the 3D cell culture market.
Provide revenues of major players of the market such as Thermo-fisher scientific ltd, Sigma-aldrich.
Provide you various the regulatory policies which are affecting the global 3D cell culture market.

How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global 3D cell culture market offers the longest chain of market segmentation covering major market segmentation based on products, application and end users. The report tracks the major market trends in the global 3D cell culture market such as technological advancement, funding initiatives from government and so on. For each market segments covered in global 3D cell culture market report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the 3D cell culture industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data.

Key Findings of the global 3D cell culture market:

The 3D cells cultures are usually grown in a small capsule or bioreactor in which the cell can grow in any shape 3d or spheroid
North America is anticipated to account the largest revenue share in 2016.
Advantages of 3D cell culture are proximity of other cells on all side behavior similar to invivo condition and more accurate representation of cyto architecture.
Increasing government support
Partnership and acquisition is the key strategy adopted by the various market players of global 3D cell culture market.
Cancer and stem cell research is the major segment of application.

Table of Content

1. INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. MARKET SCOPE

2. MARKET OVERVIEW

2.1. GLOBAL 3D CELL CULTURE MARKET: EVOLUTION & TRANSITION

2.2. INDUSTRY STRUCTURE

2.3. MANUFACTURING PROCESS

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1. TOP 5 FINDINGS

2.5.2. TOP 5 OPPORTUNITY MARKETS

2.5.3. TOP 5 COMPANIES

2.5.4. TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1. INVESTMENT VS. ADOPTION MODEL

2.7.2. 360 DEGREE INDUSTRY ANALYSIS

2.7.3. PORTERS 5 FORCE MODEL

2.7.4. SEE-SAW ANALYSIS

2.7.5. PRICING ANALYSIS

2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.7.7. ROI ANALYSIS

2.7.8. GAP ANALYSIS

2.8. COMPETITIVE ANALYSIS

2.8.1. KEY STRATEGIES AND ANALYSIS

2.8.2. MARKET SHARE

2.8.3. TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

3.1. MARKET DRIVERS & MARKET IMPACT

3.1.1. INCREASING CELL BASED RESEARCH

3.1.2. NEW INNOVATIONS IN CELL CULTURE

3.1.3. TECHNOLOGICAL ADVANCEMENTS IN CELL BIOLOGY RESEARCH

3.1.4. RISING FUNDING FOR RESEARCH RELATED ACTIVITIES

3.1.5. ADOPTION OF 3D CELL CULTURE TECHNOLOGY

3.2. MARKET RESTRAINTS & MARKET IMPACT

3.2.1. HIGH INVESTMENTS FOR CELL BIOLOGY RESEARCH

3.2.2. SHORTAGE OF INFRASTRUCTURE FOR CELL BASED RESEARCH IN EMERGING COUNTRIES

3.2.3. STRINGENT REGULATORY RULES DELAYING PRODUCT APPROVAL

3.3. MARKET OPPORTUNITIES

3.3.1. GROWING DEMAND FOR ORGAN TRANSPLANT

3.3.2. INCREASING R&D INVESTMENTS

3.3.3. GROWING HEALTHCARE MARKET

3.4. MARKET CHALLENGES

3.4.1. VARIATION IN 3D CELL CULTURE PRODUCTS

3.4.2. VARYING REGULATORY COMPLIANCE RULES.

4. MARKET SEGMENTATION

4.1. GLOBAL 3D CELL CULTURE MARKET BY TECHNOLOGY 2014-2023

4.1.1. MARKET DEFINITION AND SCOPE

4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.1.4. OPPORTUNITY MATRIX

4.1.5. MARKET SEGMENTATION

4.1.5.1. WITHOUT SCAFFOLD 2014-2023 ($ MILLION)

4.1.5.1.1. APPLICATIONS

4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.1.5. KEY CONCLUSIONS

4.1.5.1.6. WITHOUT SCAFFOLD BY SUB SEGMENTS

4.1.5.1.6.1. 3D BIOREACTORS

4.1.5.1.6.2. 3D PETRI-DISHES

4.1.5.1.6.3. 3D BIO-PRINTING

4.1.5.1.6.4. MICROFLUIDICS

4.1.5.1.6.5. HANGING DROP PLATES

4.1.5.2. WITH SCAFFOLD 2014-2023

4.1.5.2.1. APPLICATIONS

4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.2.5. KEY CONCLUSIONS

4.1.5.2.6. WITH SCAFFOLD BY SUB SEGMENTS

4.1.5.2.6.1. MICRO-PATTERNED SURFACES

4.1.5.2.6.2. HYDROGELS/ECM

4.1.5.2.6.3. SOLID STRUCTURE SCAFFOLD

4.2. GLOBAL 3D CELL CULTURE MARKET BY APPLICATIONS 2014-2023 ($ MILLION)

4.2.1. MARKET DEFINITION AND SCOPE

4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.2.4. OPPORTUNITY MATRIX

4.2.5. MARKET SEGMENTATION

4.2.5.1. TISSUE ENGINEERING 2014-2023 ($ MILLION)

4.2.5.1.1. APPLICATIONS

4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.1.5. KEY CONCLUSIONS

4.2.5.2. CELL BASED ASSAY 2014-2023 ($ MILLION)

4.2.5.2.1. APPLICATIONS

4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.2.5. KEY CONCLUSIONS

4.2.5.3. ONCOLOGY 2014-2023 ($ MILLION)

4.2.5.3.1. APPLICATIONS

4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.3.5. KEY CONCLUSIONS

4.2.5.4. IN VIVO APPLICATIONS OF STEM CELLS 2014-2023 ($ MILLION)

4.2.5.4.1. APPLICATIONS

4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.4.5. KEY CONCLUSIONS

4.2.5.5. 3D PRINTING 2014-2023 ($ MILLION)

4.2.5.5.1. APPLICATIONS

4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.5.5. KEY CONCLUSIONS

4.2.5.6. OTHER APPLICATIONS 2014-2023 ($ MILLION)

4.2.5.6.1. APPLICATIONS

4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.6.5. KEY CONCLUSIONS

4.3. GLOBAL 3D CELL CULTURE MARKET BY END USERS 2014-2023 ($ MILLION)

4.3.1. MARKET DEFINITION AND SCOPE

4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.3.4. OPPORTUNITY MATRIX

4.3.5. MARKET SEGMENTATION

4.3.5.1. BIOTECHNOLOGY, BIOPHARMACEUTICAL & PHARMACEUTICAL INDUSTRIES

4.3.5.1.1. APPLICATIONS

4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.1.5. KEY CONCLUSIONS

4.3.5.2. RESEARCH LABORATORIES

4.3.5.2.1. APPLICATIONS

4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.2.5. KEY CONCLUSIONS

4.3.5.3. HOSPITALS & DIAGNOSTICS CENTERS

4.3.5.3.1. APPLICATIONS

4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.3.5. KEY CONCLUSIONS

4.3.5.4. OTHER END USERS

4.3.5.4.1. APPLICATIONS

4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.4.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIES

5.1.1. LIST OF M&A

5.1.2. LIST OF JV

5.1.3. LIST OF PRODUCT LAUNCHES

5.1.4. LIST OF PARTNERSHIP

5.2. TOP 10 COMPANY ANALYSIS – DASHBOARD

6. GLOBAL 3D CELL CULTURE MARKET BY REGION (REVENUE ANALYSIS) 2014-2023 ($ MILLION)

6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.3. OPPORTUNITY MATRIX

6.4. GEOGRAPHIC SEGMENTATION

6.4.1. NORTH AMERICA

6.4.1.1. INDUSTRY APPLICATION ANALYSIS

6.4.1.2. TOP COUNTRY ANALYSIS

6.4.1.2.1. U.S.

6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.1.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.1.2.1.3. PRICE ANALYSIS

6.4.1.2.1.4. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.1.5. KEY CONCLUSIONS

6.4.1.2.2. CANADA

6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.2.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.1.2.2.3. PRICE ANALYSIS

6.4.1.2.2.4. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.2.5. KEY CONCLUSIONS

6.4.2. EUROPE

6.4.2.1. INDUSTRY APPLICATION ANALYSIS

6.4.2.2. TOP COUNTRY ANALYSIS

6.4.2.2.1. UK

6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.1.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.2.2.1.3. PRICE ANALYSIS

6.4.2.2.1.4. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.1.5. KEY CONCLUSIONS

6.4.2.2.2. FRANCE

6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.2.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.2.2.2.3. PRICE ANALYSIS

6.4.2.2.2.4. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.2.5. KEY CONCLUSIONS

6.4.2.2.3. GERMANY

6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.3.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.2.2.3.3. PRICE ANALYSIS

6.4.2.2.3.4. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.3.5. KEY CONCLUSIONS

6.4.2.2.4. SPAIN

6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.4.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.2.2.4.3. PRICE ANALYSIS

6.4.2.2.4.4. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.4.5. KEY CONCLUSIONS

6.4.2.2.5. ITALY

6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.5.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.2.2.5.3. PRICE ANALYSIS

6.4.2.2.5.4. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.5.5. KEY CONCLUSIONS

6.4.2.2.6. REST OF EUROPE

6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.6.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.2.2.6.3. PRICE ANALYSIS

6.4.2.2.6.4. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.6.5. KEY CONCLUSIONS

6.4.3. ASIA PACIFIC

6.4.3.1. INDUSTRY APPLICATION ANALYSIS

6.4.3.2. TOP COUNTRY ANALYSIS

6.4.3.2.1. CHINA

6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.1.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.3.2.1.3. PRICE ANALYSIS

6.4.3.2.1.4. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.1.5. KEY CONCLUSIONS

6.4.3.2.2. INDIA

6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.2.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.3.2.2.3. PRICE ANALYSIS

6.4.3.2.2.4. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.2.5. KEY CONCLUSIONS

6.4.3.2.3. JAPAN

6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.3.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.3.2.3.3. PRICE ANALYSIS

6.4.3.2.3.4. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.3.5. KEY CONCLUSIONS

6.4.3.2.4. SOUTH KOREA

6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.4.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.3.2.4.3. PRICE ANALYSIS

6.4.3.2.4.4. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.4.5. KEY CONCLUSIONS

6.4.3.2.5. AUSTRALIA

6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.5.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.3.2.5.3. PRICE ANALYSIS

6.4.3.2.5.4. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.5.5. KEY CONCLUSIONS

6.4.3.2.6. REST OF ASIA PACIFIC

6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.6.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.3.2.6.3. PRICE ANALYSIS

6.4.3.2.6.4. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.6.5. KEY CONCLUSIONS

6.4.4. ROW

6.4.4.1. INDUSTRY APPLICATION ANALYSIS

6.4.4.2. TOP COUNTRY ANALYSIS

6.4.4.2.1. LATIN AMERICA

6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.1.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.4.2.1.3. PRICE ANALYSIS

6.4.4.2.1.4. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.1.5. KEY CONCLUSIONS

6.4.4.2.2. MIDDLE EAST & NORTH AFRICA

6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.2.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.4.2.2.3. PRICE ANALYSIS

6.4.4.2.2.4. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.2.5. KEY CONCLUSIONS

6.4.4.2.3. AFRICA

6.4.4.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.3.2. MARKET REVENUES 2014-2023 ($ MILLION)

6.4.4.2.3.3. PRICE ANALYSIS

6.4.4.2.3.4. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.3.5. KEY CONCLUSIONS

7. COMPANY PROFILES

7.1. ARMACELL GMBH

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY INNOVATION SECTOR

7.1.4. STRATEGIC INITIATIVES

7.1.5. SCOT ANALYSIS

7.2. BASF SE

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY INNOVATION SECTOR

7.2.4. STRATEGIC INITIATIVES

7.2.5. SCOT ANALYSIS

7.3. FLETCHER INSULATION

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY INNOVATION SECTOR

7.3.4. STRATEGIC INITIATIVES

7.3.5. SCOT ANALYSIS

7.4. JOHNS MANVILLE INC.

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY INNOVATION SECTOR

7.4.4. STRATEGIC INITIATIVES

7.4.5. SCOT ANALYSIS

7.5. KINGSPAN GROUP PLC

7.5.1. OVERVIEW

7.5.2. PRODUCT PORTFOLIO

7.5.3. KEY INNOVATION SECTOR

7.5.4. STRATEGIC INITIATIVES

7.5.5. SCOT ANALYSIS

7.6. KNAUF INSULATION GMBH

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY INNOVATION SECTOR

7.6.4. STRATEGIC INITIATIVES

7.6.5. SCOT ANALYSIS

7.7. OWENS CORNING

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY INNOVATION SECTOR

7.7.4. STRATEGIC INITIATIVES

7.7.5. SCOT ANALYSIS

7.8. PAROC

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY INNOVATION SECTOR

7.8.4. STRATEGIC INITIATIVES

7.8.5. SCOT ANALYSIS

7.9. ROCKWOOL INTERNATIONAL A/S

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY INNOVATION SECTOR

7.9.4. STRATEGIC INITIATIVES

7.9.5. SCOT ANALYSIS

7.10. SAINT-GOBAIN SA

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY INNOVATION SECTOR

7.10.4. STRATEGIC INITIATIVES

7.10.5. SCOT ANALYSIS

7.11. LONZA LTD

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY INNOVATION SECTOR

7.11.4. STRATEGIC INITIATIVES

7.11.5. SCOT ANALYSIS

7.12. SYNTHECON INC.,

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY INNOVATION SECTOR

7.12.4. STRATEGIC INITIATIVES

7.12.5. SCOT ANALYSIS

7.13. PLURISTEM THERAPEUTICS LTD.,

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY INNOVATION SECTOR

7.13.4. STRATEGIC INITIATIVES

7.13.5. SCOT ANALYSIS

7.14. ORGANOGENIX INC.,

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY INNOVATION SECTOR

7.14.4. STRATEGIC INITIATIVES

7.14.5. SCOT ANALYSIS

7.15. VIVO BIOSCIENCE INC.,

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY INNOVATION SECTOR

7.15.4. STRATEGIC INITIATIVES

7.15.5. SCOT ANALYSIS

LIST OF TABLES

1. GLOBAL 3D CELL CULTURE MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)

2. GLOBAL WITHOUT SCAFFOLD BY GEOGRAPHY 2014-2023 ($ MILLION)

3. GLOBAL 3D BIOREACTORS BY GEOGRAPHY 2014-2023 ($ MILLION)

4. GLOBAL 3D PETRI-DISHES BY GEOGRAPHY 2014-2023 ($ MILLION)

5. GLOBAL 3D BIO-PRINTING BY GEOGRAPHY 2014-2023 ($ MILLION)

6. GLOBAL MICROFLUIDICS BY GEOGRAPHY 2014-2023 ($ MILLION)

7. GLOBAL HANGING DROP PLATES BY GEOGRAPHY 2014-2023 ($ MILLION)

8. GLOBAL WITH SCAFFOLD MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

9. GLOBAL MICRO-PATTERNED BY GEOGRAPHY 2014-2023 ($ MILLION)

10. GLOBAL HYDROGELS/ECM BY GEOGRAPHY 2014-2023 ($ MILLION)

11. GLOBAL SOLID STRUCTURE SCAFFOLD BY GEOGRAPHY 2014-2023 ($ MILLION)

12. GLOBAL 3D CELL CULTURE MARKET BY APPLICATIONS 2014-2023 ($ MILLION)

13. GLOBAL TISSUE ENGINEERING BY GEOGRAPHY 2014-2023 ($ MILLION)

14. GLOBAL CELL BASED ASSAY BY GEOGRAPHY 2014-2023 ($ MILLION)

15. GLOBAL ONCOLOGY BY GEOGRAPHY 2014-2023 ($ MILLION)

16. GLOBAL IN VIVO APPLICATIONS OF STEM CELLS BY GEOGRAPHY 2014-2023 ($ MILLION)

17. GLOBAL 3D PRINTING BY GEOGRAPHY 2014-2023 ($ MILLION)

18. GLOBAL OTHER APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)

19. GLOBAL 3D CELL CULTURE MARKET BY END USERS 2014-2023 ($ MILLION)

20. GLOBAL LIFE SCIENCE INDUSTRY BY GEOGRAPHY 2014-2023 ($ MILLION)

21. GLOBAL RESEARCH LABORATORIES BY GEOGRAPHY 2014-2023 ($ MILLION)

22. GLOBAL HOSPITALS AND DIAGNOSTIC CENTERS BY GEOGRAPHY 2014-2023 ($ MILLION)

23. GLOBAL OTHER END USERS BY GEOGRAPHY 2014-2023 ($ MILLION)

24. NORTH AMERICA 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

25. EUROPE 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

26. ASIA PACIFIC 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

27. REST OF THE WORLD 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

1. GLOBAL 3D CELL CULTURE MARKET BY WITHOUT SCAFFOLD 2014-2023 ($ MILLION)

2. GLOBAL 3D CELL CULTURE MARKET BY 3D BIOREACTOR 2014-2023 ($ MILLION)

3. GLOBAL 3D CELL CULTURE MARKET BY 3D PETRI DISHES 2014-2023 ($ MILLION)

4. GLOBAL 3D CELL CULTURE MARKET BY 3D BIO-PRINTING 2014-2023 ($ MILLION)

5. GLOBAL 3D CELL CULTURE MARKET BY HANGING DROP PLATES 2014-2023 ($ MILLION)

6. GLOBAL 3D CELL CULTURE MARKET BY MICROFLUIDICS 2014-2023 ($ MILLION)

7. GLOBAL 3D CELL CULTURE MARKET BY WITH SCAFFOLD 2014-2023 ($ MILLION)

8. GLOBAL 3D CELL CULTURE MARKET BY MICRO-PATTERNED 2014-2023 ($ MILLION)

9. GLOBAL 3D CELL CULTURE MARKET BY HYDROGELS/ECM 2014-2023 ($ MILLION)

10. GLOBAL 3D CELL CULTURE MARKET BY SOLID STRUCTURE 2014-2023 ($ MILLION)

11. GLOBAL 3D CELL CULTURE MARKET BY TISSUE ENGINEERING 2014-2023 ($ MILLION)

12. GLOBAL 3D CELL CULTURE MARKET BY CELL BASED ASSAY 2014-2023 ($ MILLION)

13. GLOBAL 3D CELL CULTURE MARKET BY IN VIVO APPLICATIONS 2014-2023 ($ MILLION)

14. GLOBAL 3D CELL CULTURE MARKET BY OTHER APPLICATIONS 2014-2023 ($ MILLION)

15. GLOBAL 3D CELL CULTURE MARKET BY LIFE SCIENCE INDUSTRY 2014-2023 ($ MILLION)

16. GLOBAL 3D CELL CULTURE MARKET BY RESEARCH LABORATORIES 2014-2023 ($ MILLION)

17. GLOBAL 3D CELL CULTURE MARKET BY HOSPITAL AND DIAGNOSTICS CENTERS 2014-2023 ($ MILLION)

18. GLOBAL 3D CELL CULTURE MARKET BY OTHER END USERS 2014-2023 ($ MILLION)

19. UNITED STATES (U.S.) 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

20. CANADA 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

21. UNITED KINGDOM (UK) 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

22. FRANCE 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

23. GERMANY 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

24. SPAIN 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

25. ITALY 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

26. ROE 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

27. INDIA 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

28. CHINA 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

29. JAPAN 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

30. KOREA 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

31. AUSTRALIA 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

32. ROAPAC 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

33. LATIN AMERICA 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

34. MENA 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

35. AFRICA 3D CELL CULTURE MARKET 2014-2023 ($ MILLION)

Enquiry before Buying

FAQ

How can I purchase a report?

We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.

How safe is to use my credit card? Is my information secure?

We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.

Can I get a discount?

We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.

I want to buy only a chapter. I don't need complete report.

Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.

Can I get reports on my desired topic specially which is not available in your current portfolio?

Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.

When do I get access to the report(s) that I have purchased?

We will email you your purchased report right after we receive your payment through any of the payment options.

Will I receive any invoice for my purchase?

Yes we will email you invoice/payment confirmation with the order details once we receive your payment.

In what format will the reports be available in?

All the reports will be available in PDF format for download.

Request for Sample

Name*

Email Id*

Phone

Designation

Company Name

Country

Report Title

Type Characters*

OUR LOCATION

+91 9977002116

Thank you for your request!

Thank you for downloading..!

Global 3D Cell Culture Market-Technologies, Market share and Industry Forecast to 2024

FAQ

Request for Sample

UPCOMING REPORTS